AccessPak for HIV PEP Expanded with Kaletra and Metformin and repaglinide
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Metformin and repaglinide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: metformin / repaglinide
Brand name: PrandiMet
Synonyms: Repaglinide and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Metformin and saxagliptin
- AccessPak for HIV PEP Expanded with Kaletra-Metformin and sitagliptin
- AccessPak for HIV PEP Expanded with Kaletra-Metformin Extended-Release Tablets
- AccessPak for HIV PEP Expanded with Kaletra-Metformin Hydrochloride
- AccessPak for HIV PEP Expanded with Kaletra-Metformin Oral Solution
- AccessPak for HIV PEP Expanded with Kaletra-Metformin Tablets
- Metformin and repaglinide-AccessPak for HIV PEP Expanded with Viracept
- Metformin and repaglinide-Accolate
- Metformin and repaglinide-Accretropin
- Metformin and repaglinide-Accucaine
- Metformin and repaglinide-AccuHist Drops
- Metformin and repaglinide-AccuHist PDX Drops